MoneyWorks4Me

Medicamen Biotech - Quaterly Results

10 Aug 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 330.88 millions, about 20.19% up against Rs. 275.30 millions recorded during the year-ago period.A slender decline of -13.61% was recorded to Rs. 35.86  millions from Rs. 41.51 millions in the corresponding previous quarter.OP of the company witnessed a marginal growth to 66.19 millions from 61.19 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 330.88 275.30 20.19 330.88 275.30 20.19 1154.45 1101.46 4.81
Other Income 9.62 0.79 1117.72 9.62 0.79 1117.72 17.20 7.54 128.12
PBIDT 66.19 61.19 8.17 66.19 61.19 8.17 252.74 203.35 24.29
Interest 7.67 0.44 1643.18 7.67 0.44 1643.18 14.01 10.64 31.67
PBDT 58.52 60.75 -3.67 58.52 60.75 -3.67 238.73 192.71 23.88
Depreciation 15.27 13.30 14.81 15.27 13.30 14.81 57.71 25.20 129.01
PBT 43.25 47.45 -8.85 43.25 47.45 -8.85 181.02 167.51 8.07
TAX 7.39 5.94 24.41 7.39 5.94 24.41 31.97 42.65 -25.04
Deferred Tax -2.39 -0.66 262.12 -2.39 -0.66 262.12 -7.80 1.19 -755.46
PAT 35.86 41.51 -13.61 35.86 41.51 -13.61 149.05 124.86 19.37
Equity 122.17 122.17 0.00 122.17 122.17 0.00 122.17 122.17 0.00
PBIDTM(%) 20.00 22.23 -10.00 20.00 22.23 -10.00 21.89 18.46 18.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..